ISSN 1674-3865  CN 21-1569/R
主管:国家卫生健康委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

中国中西医结合儿科学 ›› 2016, Vol. 8 ›› Issue (3): 277-279.doi: 10.3969/j.issn.1674-3865.2016.03.009

• 综述 • 上一篇    下一篇

缓控释制剂与儿科剂型开发

王峰,孙倩,宋光熠   

  1. 100101 沈阳,辽宁医药职业学院药学系药物制剂教研室(王峰),药品质量检测技术教研室(孙倩)|医学基础部药理教研室(宋光熠)
  • 出版日期:2016-06-25 发布日期:2018-11-19
  • 通讯作者: 孙倩,E-mail:122003459@qq.com
  • 作者简介:王峰(1980-),男,讲师。研究方向:儿童药物制剂的研究
  • 基金资助:
    辽宁省科学技术计划重大、重点项目(600569)

Sustained and controlled release preparation and development of pediatric preparation type

WANG Feng, SUN Qian,SONG Guangyi   

  1. Liaoning Vocational College of Medicine,Shengyang 110101,China.
  • Online:2016-06-25 Published:2018-11-19

摘要:
缓控释制剂是新药研发的热点剂型,具有给药次数少,作用时间长,不良反应小等特点,与儿科用药的需求相适应。本文通过对已发表的代表性文献进行分析和归纳总结,阐述缓控释制剂的特点和儿科临床用药不良反应率高等问题,为缓控释制剂在儿科领域的开发提供参考。

关键词: 缓控释制剂, 剂型, 不良反应, 儿科

Abstract:
Sustained and controlled release preparation is a hot spot in the research and development of new drugs. It has the characteristics of less dosage, longer action time and fewer adverse reactions. In this paper, through the analysis and summary of published literatures, the characteristics of sustained and controlled release preparation and the problems related to higher rate of clinical adverse reactions were analyzed in order to provide reference for the development of sustained and controlled release preparation in pediatrics.

Key words: Sustained and controlled release preparations, Preparation type, Adverse reactions, Pediatrics